Skip to main content
Erschienen in: Zeitschrift für Rheumatologie 1/2024

08.09.2022 | Originalien

Investigating performance-based hand functions in patients with systemic sclerosis

verfasst von: Emre Alp Akatay, Deniz Bayraktar, Eda Otman, Oguz Ustun, Idil Kurut Aysin, Devrim Can Sarac, Busranur Atalay, Irem Ramazanoglu, Ilyas Tekin, Tugba Kurum, Sercan Gucenmez, Mustafa Ozmen, Servet Akar

Erschienen in: Zeitschrift für Rheumatologie | Sonderheft 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Objective

Systemic sclerosis (SSc) is a connective tissue disorder characterized by collagen deposits in various organs. Skin involvement is one of the most common symptoms and along with vascular damage, may deteriorate hand functions. However, the status of hand functions has generally been investigated using patient-reported measures in patients with SSc. The aim of the present study was to investigate performance-based hand functions in patients with SSc using the Sollerman Hand Function Test (SHFT).

Methods

A total of 39 patients with SSc (33 females) were included in the study. Twenty-four patients were classified as limited cutaneous SSc (lcSSc), while 15 patients were classified as diffuse cutaneous SSc (dcSSc). Hand-related physical characteristics were evaluated using the Modified Hand Mobility in Scleroderma Test, grip strength, and pinch strengths. The Duruoz Hand Index (Cochin Hand Functional Disability Scale), Disability of Arm, Shoulder, and Hand Questionnaire, Health Assessment Questionnaire, and Scleroderma Health Assessment Questionnaire were used as patient-reported measures. Performance-based hand functions were evaluated using SHFT.

Results

No significant differences were observed between lcSSc and dcSSc subtypes regarding performance-based and patient-reported hand functions (p > 0.05). SHFT scores significantly correlated with hand-related physical characteristics and patient-reported hand functions (p < 0.05). The highest correlation was determined between SHFT and the Duruoz Hand Index (rho: −0.652, p < 0.001).

Conclusion

According to our results, performance-based hand functions seem not to be affected by disease subtype. Performance-based hand functions may partially be captured by the patient-reported outcomes, especially the Duruoz Hand Index, in patients with SSc.
Literatur
2.
Zurück zum Zitat Gabrielli A, Avvedimento EV, Krieg T (2009) Scleroderma. N Engl J Med 360:1989–2003CrossRefPubMed Gabrielli A, Avvedimento EV, Krieg T (2009) Scleroderma. N Engl J Med 360:1989–2003CrossRefPubMed
3.
4.
Zurück zum Zitat Brower LM, Poole JL (2004) Reliability and validity of the Duruoz Hand Index in persons with systemic sclerosis (scleroderma). Arthritis Rheum 51:805–809CrossRefPubMed Brower LM, Poole JL (2004) Reliability and validity of the Duruoz Hand Index in persons with systemic sclerosis (scleroderma). Arthritis Rheum 51:805–809CrossRefPubMed
5.
Zurück zum Zitat Poole JL, Gallegos M, O’Linc S (2000) Reliability and validity of the Arthritis Hand Function Test in adults with systemic sclerosis (scleroderma). Arthritis Care Res 13:69–73CrossRefPubMed Poole JL, Gallegos M, O’Linc S (2000) Reliability and validity of the Arthritis Hand Function Test in adults with systemic sclerosis (scleroderma). Arthritis Care Res 13:69–73CrossRefPubMed
6.
Zurück zum Zitat Sollerman C, Ejeskär A (1995) Sollerman hand function test. A standardised method and its use in tetraplegic patients. Scand J Plast Reconstr Surg Hand Surg 29:167–176CrossRefPubMed Sollerman C, Ejeskär A (1995) Sollerman hand function test. A standardised method and its use in tetraplegic patients. Scand J Plast Reconstr Surg Hand Surg 29:167–176CrossRefPubMed
7.
Zurück zum Zitat van den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 72:1747–1755CrossRefPubMed van den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 72:1747–1755CrossRefPubMed
8.
Zurück zum Zitat Khanna D, Furst DE, Clements PJ et al (2017) Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis. J Scleroderma Relat Disord 2:11–18CrossRefPubMed Khanna D, Furst DE, Clements PJ et al (2017) Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis. J Scleroderma Relat Disord 2:11–18CrossRefPubMed
9.
Zurück zum Zitat Tore NG, Sari F, Sarac DC et al (2020) Inter-rater reliability of modified hand mobility in scleroderma test. Int J Rheum Dis 23:203–206CrossRefPubMed Tore NG, Sari F, Sarac DC et al (2020) Inter-rater reliability of modified hand mobility in scleroderma test. Int J Rheum Dis 23:203–206CrossRefPubMed
10.
Zurück zum Zitat Mackin EJ, Callahan AD, Osterman AL, Skirven TM, Schneider L (2002) Hunter, Mackin & Callahan’s rehabilitation of the hand and upper extremity, 5th edn. Mosby, St Louis, pp 263–284 Mackin EJ, Callahan AD, Osterman AL, Skirven TM, Schneider L (2002) Hunter, Mackin & Callahan’s rehabilitation of the hand and upper extremity, 5th edn. Mosby, St Louis, pp 263–284
11.
Zurück zum Zitat Duruöz MT, Poiraudeau S, Fermanian J et al (1996) Development and validation of a rheumatoid hand functional disability scale that assesses functional handicap. J Rheumatol 23:1167–1172PubMed Duruöz MT, Poiraudeau S, Fermanian J et al (1996) Development and validation of a rheumatoid hand functional disability scale that assesses functional handicap. J Rheumatol 23:1167–1172PubMed
12.
Zurück zum Zitat Duger T, Yakut E, Oksuz C, Yorukan S, Semin Bilgutay B, Ayhan C, Leblebicioglu G, Kayıhan H, Kırdı N, Yakut Y, Guler C (2006) Reliability and validity of the Turkish version of the disabilities of the arm, shoulder and hand (DASH) questionnaire. Fizyoterapi Rehabilitasyon 17:99–107 Duger T, Yakut E, Oksuz C, Yorukan S, Semin Bilgutay B, Ayhan C, Leblebicioglu G, Kayıhan H, Kırdı N, Yakut Y, Guler C (2006) Reliability and validity of the Turkish version of the disabilities of the arm, shoulder and hand (DASH) questionnaire. Fizyoterapi Rehabilitasyon 17:99–107
13.
Zurück zum Zitat Temiz Karadag D, Karakas F, Tekeoglu S et al (2019) Validation of Turkish version of the Scleroderma health assessment questionnaire. Clin Rheumatol 38:1917–1923CrossRefPubMed Temiz Karadag D, Karakas F, Tekeoglu S et al (2019) Validation of Turkish version of the Scleroderma health assessment questionnaire. Clin Rheumatol 38:1917–1923CrossRefPubMed
14.
Zurück zum Zitat Sandqvist G, Eklund M, Akesson A, Nordenskiöld U (2004) Daily activities and hand function in women with scleroderma. Scand J Rheumatol 33:102–107CrossRefPubMed Sandqvist G, Eklund M, Akesson A, Nordenskiöld U (2004) Daily activities and hand function in women with scleroderma. Scand J Rheumatol 33:102–107CrossRefPubMed
15.
Zurück zum Zitat Erol K, Gok K, Cengiz G, Ozgocmen S (2018) Hand functions in systemic sclerosis and rheumatoid arthritis and influence on clinical variables. Int J Rheum Dis 21:249–252CrossRefPubMed Erol K, Gok K, Cengiz G, Ozgocmen S (2018) Hand functions in systemic sclerosis and rheumatoid arthritis and influence on clinical variables. Int J Rheum Dis 21:249–252CrossRefPubMed
16.
Zurück zum Zitat Schouffoer AA, van der Giesen FJ, Beaart-van de Voorde LJ et al (2016) Validity and responsiveness of the Michigan hand questionnaire in patients with systemic sclerosis. Rheumatology (Oxford) 55:1386–1393CrossRefPubMed Schouffoer AA, van der Giesen FJ, Beaart-van de Voorde LJ et al (2016) Validity and responsiveness of the Michigan hand questionnaire in patients with systemic sclerosis. Rheumatology (Oxford) 55:1386–1393CrossRefPubMed
17.
Zurück zum Zitat Perera A, Fertig N, Lucas M et al (2007) Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody. Arthritis Rheum 56:2740–2746CrossRefPubMed Perera A, Fertig N, Lucas M et al (2007) Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody. Arthritis Rheum 56:2740–2746CrossRefPubMed
18.
Zurück zum Zitat Sandqvist G, Nilsson JÅ, Wuttge DM, Hesselstrand R (2014) Development of a modified hand mobility in scleroderma (HAMIS) test and its potential as an outcome measure in systemic sclerosis. J Rheumatol 41:2186–2192CrossRefPubMed Sandqvist G, Nilsson JÅ, Wuttge DM, Hesselstrand R (2014) Development of a modified hand mobility in scleroderma (HAMIS) test and its potential as an outcome measure in systemic sclerosis. J Rheumatol 41:2186–2192CrossRefPubMed
19.
Zurück zum Zitat Mouthon L, Carpentier PH, Lok C et al (2017) Controlling the digital ulcerative disease in systemic sclerosis is associated with improved hand function. Semin Arthritis Rheum 46:759–766CrossRefPubMed Mouthon L, Carpentier PH, Lok C et al (2017) Controlling the digital ulcerative disease in systemic sclerosis is associated with improved hand function. Semin Arthritis Rheum 46:759–766CrossRefPubMed
Metadaten
Titel
Investigating performance-based hand functions in patients with systemic sclerosis
verfasst von
Emre Alp Akatay
Deniz Bayraktar
Eda Otman
Oguz Ustun
Idil Kurut Aysin
Devrim Can Sarac
Busranur Atalay
Irem Ramazanoglu
Ilyas Tekin
Tugba Kurum
Sercan Gucenmez
Mustafa Ozmen
Servet Akar
Publikationsdatum
08.09.2022
Verlag
Springer Medizin
Erschienen in
Zeitschrift für Rheumatologie / Ausgabe Sonderheft 1/2024
Print ISSN: 0340-1855
Elektronische ISSN: 1435-1250
DOI
https://doi.org/10.1007/s00393-022-01267-5

Weitere Artikel der Sonderheft 1/2024

Zeitschrift für Rheumatologie 1/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.